Effects of nitroprusside and dopamine on pulmonary arterial vasculature in children after cardiac surgery. 1979

L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis

The hemodynamic effects of nitroprusside and dopamine were studied in 28 children early after intracardiac repair. Children were placed in six groups, five according to their anatomic lesion and one made up of those who had postoperative pulmonary artery hypertension, to evaluate the possible differences in response of the pulmonary arterial vasculature to the drugs. Seven children had repair of an atrial septal defect; six, repair of tetralogy of Fallot; four, repair of ventricular septal defect; five, surgery for pulmonary stenosis; one, closure of a left ventricular to right atrial tunnel; and five, postoperative pulmonary artery hypertension. Dopamine was infused at 8 microgram/kg/min, and nitroprusside at 3 microgram/kg/min. With dopamine, the heart rate increased an average of 10% and the cardiac index 11%; both increases were statistically significant. Changes in systemic and pulmonary vascular resistance, however, were not. With nitroprusside, the heart rate increased an average of 9% and the cardiac index 5%, while there was a significant decrease in both systemic (-20%) and pulmonary (-27%) vascular resistance. With the combination of dopamine and nitroprusside, both the cardiac index (+13%) and heart rate (+20%) increased significantly while systemic vascular resistance fell an average of 23% from control, and the pulmonary vascular resistance decreased 21%. Drug response among all five anatomic subgroups tended to be similar. We conclude that an afterload-reducing agent, such as nitroprusside and an inotropic drug such as dopamine, may have potential clinical advantages when used together in children providing heart rate does not become excessive.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D007223 Infant A child between 1 and 23 months of age. Infants
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D009599 Nitroprusside A powerful vasodilator used in emergencies to lower blood pressure or to improve cardiac function. It is also an indicator for free sulfhydryl groups in proteins. Nitroferricyanide,Sodium Nitroprusside,Cyanonitrosylferrate,Ketostix,Naniprus,Nipride,Nipruton,Nitriate,Nitropress,Nitroprussiat Fides,Nitroprusside, Disodium Salt,Nitroprusside, Disodium Salt, Dihydrate,Disodium Salt Nitroprusside,Nitroprusside, Sodium
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine

Related Publications

L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
July 1977, British heart journal,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
February 1986, International journal of clinical pharmacology, therapy, and toxicology,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
March 1991, Critical care nurse,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
November 2010, Chest,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
April 2021, Cardiology in the young,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
February 1990, Radiology,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
September 1987, Journal of applied physiology (Bethesda, Md. : 1985),
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
October 1991, Minerva anestesiologica,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
May 1980, Anesthesiology,
L W Stephenson, and L H Edmunds, and R Raphaely, and D F Morrison, and W S Hoffman, and L J Rubis
June 1976, Der Anaesthesist,
Copied contents to your clipboard!